医薬品受託販売アウトソーシング市場- 世界の産業規模、シェア、動向、機会、予測、サービス別、治療分野別、地域別、競合別、2019年～2029年

世界の医薬品受託販売アウトソーシング市場の2023年の市場規模は71億1,000万米ドルで、2029年までの予測期間のCAGRは5.25%で、着実な成長が予測されています。

進化を続ける製薬業界の情勢において、企業は常に業務の合理化、コスト削減、効率性の最大化のための革新的な方法を模索しています。そのような戦略の1つとして近年大きな注目を集めているのが、医薬品受託販売アウトソーシング（CSO）です。これは、製薬企業が営業・マーケティング機能を専門のサービス・プロバイダーにアウトソーシングすることで、研究開発などのコアコンピタンスに集中できるようにするアプローチです。世界の医薬品CSO市場は、ヘルスケアシステムの複雑化、コスト削減へのプレッシャーの高まり、厳しい規制、販売に特化した専門知識への需要の高まりなどの要因により、過去10年間で著しい成長を遂げています。

市場促進要因

市場の拡大・浸透が医薬品受託販売アウトソーシングの世界市場を牽引

患者中心主義への注力の高まりが医薬品受託販売アウトソーシングの世界市場を牽引

主な市場課題

規制への対応

データセキュリティとプライバシー

主な市場動向

技術的進歩

セグメント別インサイト

サービス別インサイト

地域別インサイト

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 医薬品受託販売アウトソーシングの世界市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • サービス別（パーソナルプロモーション（プロモーション営業チーム、キーアカウントマネジメント、欠員管理）、ノンプロモーション（テレディテーリング、インタラクティブEディテーリング、カスタマーサービス、メディカルサイエンスリエゾン、患者エンゲージメントサービス、その他）、その他）
  • 治療領域別（心血管疾患、がん、代謝性疾患、神経、整形外科疾患、感染症、その他）
  • 地域別
  • 企業別（2023年）
• 市場マップ
  • サービス別
  • 治療領域別
  • 地域別

第5章 アジア太平洋の医薬品受託販売アウトソーシング市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • サービス別
  • 治療領域別
  • 国別
• アジア太平洋地域国別分析
  • 中国
  • インド
  • オーストラリア
  • 日本
  • 韓国

第6章 欧州の医薬品受託販売アウトソーシング市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • サービス別
  • 治療領域別
  • 国別
• 欧州国別分析
  • フランス
  • ドイツ
  • スペイン
  • イタリア
  • 英国

第7章 北米の医薬品受託販売アウトソーシング市場展望

• 市場規模・予測
  • 金額別
• 市場シェアと予測
  • サービス別
  • 治療領域別
  • 国別
• 北米国別分析
  • 米国
  • メキシコ
  • カナダ

第8章 南米の医薬品受託販売アウトソーシング市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • サービス別
  • 治療領域別
  • 国別
• 南米：国別分析
  • ブラジル
  • アルゼンチン
  • コロンビア

第9章 中東・アフリカの医薬品受託販売アウトソーシング市場展望

• 市場規模と予測
  • 金額別
• 市場シェアと予測
  • サービス別
  • 治療領域別
  • 国別
• MEA：国別分析
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦

第10章 市場力学

• 促進要因
• 課題

第11章 市場動向と発展

• 最近の動向
• 製品上市
• 合併と買収

第12章 医薬品受託販売アウトソーシングの世界市場SWOT分析

第13章 ポーターのファイブフォース分析

• 業界内の競合
• 新規参入の可能性
• サプライヤーの力
• 顧客の力
• 代替品の脅威

第14章 競合情勢

• Ashfield（UDG Healthcare plc）
• inVentiv Health, Inc.（Syneos Health）
• Granard Pharmaceutical Sales & Marketing
• Vanguard Pharma, Inc.
• GTS Solution
• QFR Solutions
• Pharmaforce Ireland Ltd.
• Sales Focus, Inc.
• Amplity Health
• PharmaLex GmbH

第15章 戦略的提言

第16章 調査会社について・免責事項

Global Pharmaceutical Contract Sales Outsourcing Market was valued at USD 7.11 Billion in 2023 and is anticipated to project steady growth in the forecast period with a CAGR of 5.25% through 2029. In the ever-evolving landscape of the pharmaceutical industry, companies are constantly seeking innovative ways to streamline operations, reduce costs, and maximize efficiency. One such strategy that has gained significant traction in recent years is pharmaceutical contract sales outsourcing (CSO). This approach involves pharmaceutical companies outsourcing their sales and marketing functions to specialized service providers, allowing them to focus on core competencies such as research and development. The global pharmaceutical CSO market has witnessed remarkable growth in the past decade, driven by several factors including the increasing complexity of healthcare systems, rising pressure to cut costs, stringent regulations, and the growing demand for specialized sales expertise.

Key Market Drivers

Increasing Market Expansion and Penetration is Driving the Global Pharmaceutical Contract Sales Outsourcing Market.

In the dynamic landscape of the pharmaceutical industry, companies are increasingly turning to contract sales outsourcing (CSO) as a strategic solution to navigate complex market challenges. The global pharmaceutical CSO market is witnessing a significant surge, fueled primarily by the imperative need for market expansion and penetration. This paradigm shift reflects a strategic realignment within the industry, as pharmaceutical companies seek agile and cost-effective approaches to reach diverse markets and maximize sales potential.

The pharmaceutical sector operates in an environment characterized by stringent regulatory frameworks, evolving healthcare policies, and intensifying competition. These factors, coupled with rising R&D costs and patent expirations, have led pharmaceutical companies to reassess their sales and marketing strategies. Consequently, many are opting for CSO as a viable alternative to in-house sales teams, leveraging the expertise and infrastructure of specialized outsourcing partners.

One of the primary drivers propelling the growth of the pharmaceutical CSO market is the pursuit of global market expansion. With the increasing globalization of healthcare and the emergence of new markets, pharmaceutical companies are seeking to extend their reach beyond traditional territories. CSO enables companies to access untapped markets efficiently by leveraging the local expertise and networks of outsourcing partners. This approach not only facilitates market entry but also mitigates risks associated with unfamiliar regulatory landscapes and cultural nuances.

The growing emphasis on market penetration within existing territories further underpins the demand for CSO services. Pharmaceutical companies are increasingly focused on optimizing their sales operations to capitalize on evolving market dynamics and consumer preferences. CSO providers offer specialized sales teams equipped with the knowledge and experience to navigate complex healthcare ecosystems, establish strategic partnerships, and drive product uptake. By outsourcing sales functions, companies can streamline their operations, reduce overhead costs, and enhance flexibility in response to market fluctuations.

The advent of digital technologies is revolutionizing the pharmaceutical sales landscape, presenting both opportunities and challenges. The proliferation of online channels and digital marketing platforms has transformed how pharmaceutical products are promoted and sold. CSO providers are capitalizing on this trend by integrating digital tools and analytics into their service offerings, enabling targeted marketing campaigns, personalized engagement strategies, and real-time performance monitoring.

The COVID-19 pandemic has accelerated the adoption of remote detailing and virtual engagement models, further driving the demand for CSO services. With restrictions on in-person interactions and healthcare access, pharmaceutical companies are increasingly relying on outsourced sales teams to maintain continuity in their commercial operations. CSO providers have swiftly adapted to this paradigm shift, leveraging virtual communication technologies to ensure seamless engagement with healthcare professionals and patients.

Increasing Focus on Patient-Centricity is Driving the Global Pharmaceutical Contract Sales Outsourcing Market

In the rapidly evolving landscape of the pharmaceutical industry, a paradigm shift towards patient-centricity has become increasingly apparent. This transformative approach places the patient at the center of healthcare decisions, emphasizing their needs, preferences, and outcomes. As pharmaceutical companies strive to align with this patient-centric ethos, they are turning to specialized services to enhance their sales operations. This trend has catalyzed the growth of the Global Pharmaceutical Contract Sales Outsourcing Market, reflecting a strategic move towards optimizing engagement and improving healthcare delivery.

Patient-centricity fundamentally alters the traditional dynamics of pharmaceutical sales and marketing. Instead of solely focusing on promoting products to healthcare professionals, companies are now seeking ways to directly connect with patients, understand their experiences, and address their concerns. This shift is driven by several factors, including rising patient empowerment, increasing digital connectivity, and a growing demand for personalized healthcare solutions.

In response to these dynamics, pharmaceutical companies are leveraging contract sales outsourcing as a strategic tool to adapt and thrive in this new era. Outsourcing sales functions to specialized service providers offers numerous advantages, including access to a highly skilled and flexible workforce, cost efficiency, and expertise in diverse therapeutic areas. Moreover, outsourcing enables companies to scale their operations rapidly, penetrate new markets, and navigate complex regulatory environments effectively.

One of the key drivers propelling the growth of the pharmaceutical contract sales outsourcing market is the need for tailored, patient-centric engagement strategies. By partnering with outsourcing firms that specialize in patient engagement, pharmaceutical companies can design and implement initiatives that resonate with diverse patient populations. These initiatives may include educational programs, patient support services, and digital health solutions aimed at empowering patients, improving adherence, and enhancing health outcomes.

Another significant factor contributing to the expansion of the outsourcing market is the increasing globalization of pharmaceutical sales and marketing activities. As companies seek to expand their presence in emerging markets and navigate diverse cultural landscapes, outsourcing provides a strategic solution. By collaborating with local outsourcing partners who possess deep market knowledge and established networks, pharmaceutical companies can effectively penetrate new markets, navigate regulatory complexities, and adapt their strategies to local preferences and practices.

The evolving regulatory environment and heightened scrutiny of pharmaceutical sales practices have prompted companies to reassess their compliance procedures and risk management strategies. Outsourcing sales operations to reputable service providers with robust compliance frameworks and expertise in regulatory affairs offers companies peace of mind and ensures adherence to industry standards and regulations.

Key Market Challenges

Regulatory Compliance

Navigating the intricate web of regulatory requirements is perhaps the most prominent challenge for pharmaceutical CSO providers. Different regions have distinct regulations governing sales activities, promotional practices, and data privacy. Ensuring compliance with diverse regulatory frameworks across multiple markets demands meticulous planning and execution. Any non-compliance can lead to severe penalties, tarnished reputations, and legal repercussions. Therefore, CSO providers must invest in robust compliance mechanisms, stay updated with evolving regulations, and implement stringent monitoring processes.

Data Security and Privacy

In an era dominated by data-driven decision-making, safeguarding sensitive information has become paramount. Pharmaceutical CSO involves handling vast amounts of confidential data, including patient information, sales performance metrics, and market insights. Any breach in data security not only jeopardizes the integrity of the CSO provider but also erodes the trust of pharmaceutical clients and end-users. To address this challenge, CSO companies must invest in cutting-edge cybersecurity measures, employ encryption technologies, conduct regular audits, and enforce strict access controls to protect data throughout its lifecycle.

Key Market Trends

Technological Advancements

In an era where technological innovation is reshaping industries across the globe, the pharmaceutical sector is experiencing a significant transformation. One area witnessing notable growth is the Pharmaceutical Contract Sales Outsourcing (CSO) market. As pharmaceutical companies seek to optimize their operations and focus on core competencies, they are increasingly turning to outsourcing for sales and marketing activities. Advancements in technology have revolutionized the way pharmaceutical companies approach sales and marketing. From sophisticated data analytics to artificial intelligence (AI) and machine learning algorithms, technology is enabling CSO providers to offer tailored solutions that enhance efficiency and effectiveness.

The abundance of healthcare data, coupled with advancements in analytics tools, allows CSO providers to derive valuable insights into market trends, physician preferences, and patient behaviour. By leveraging predictive analytics, companies can optimize sales strategies, target the right healthcare professionals, and maximize ROI.

AI-powered solutions are revolutionizing sales and marketing in the pharmaceutical industry. Machine learning algorithms can analyze vast amounts of data to identify patterns and predict customer behaviour. Additionally, AI-driven chatbots and virtual assistants are improving customer engagement and providing personalized support to healthcare professionals.

With the proliferation of digital channels, pharmaceutical companies are increasingly adopting digital marketing strategies to reach healthcare professionals and patients. CSO providers leverage technologies such as social media, search engine optimization (SEO), and email marketing to deliver targeted messages and drive sales.

The COVID-19 pandemic accelerated the adoption of remote engagement technologies in the pharmaceutical industry. Virtual meetings, webinars, and remote detailing platforms enable sales representatives to engage with healthcare professionals effectively, irrespective of geographical constraints. While technological advancements offer immense opportunities, they also present challenges, particularly concerning regulatory compliance. The pharmaceutical industry operates in a highly regulated environment, with strict guidelines governing promotional activities and data privacy. CSO providers must ensure that their technological solutions comply with industry regulations, such as the Health Insurance Portability and Accountability Act (HIPAA) in the United States and the General Data Protection Regulation (GDPR) in the European Union. Robust cybersecurity measures are essential to safeguard sensitive patient information and maintain trust with clients.

Segmental Insights

Service Insights

Based on the category of service, personal promotion emerged as the dominant segment in the global market for Pharmaceutical Contract Sales Outsourcing in 2023. Personal promotion, characterized by direct interactions between pharmaceutical representatives and healthcare professionals, plays a crucial role in fostering brand awareness, educating stakeholders about products, and influencing prescribing behaviours. In an era where digital communication channels abound, face-to-face engagement remains unparalleled in its effectiveness for building trust and credibility within the medical community. This human touch is especially invaluable in complex therapeutic areas where detailed discussions and nuanced understanding are essential.

One of the primary drivers behind the prominence of personal promotion is its ability to tailor messaging and educational materials to the specific needs of healthcare professionals. Through one-on-one interactions, pharmaceutical representatives can adapt their communication style and content based on the audience's preferences and expertise. This personalized approach enhances the receptivity of healthcare professionals to promotional efforts, leading to greater engagement and, ultimately, increased prescription rates.

Regional Insights

North America emerged as the dominant region in the global Pharmaceutical Contract Sales Outsourcing market in 2023, holding the largest market share in terms of value. North America boasts a mature and robust pharmaceutical industry, characterized by a high level of innovation, extensive research and development (R&D) activities, and a large market for prescription drugs. With a vast array of pharmaceutical companies ranging from multinational giants to small-scale enterprises, the region offers ample opportunities for contract sales outsourcing firms to collaborate and thrive.

Key Market Players

Ashfield (UDG Healthcare plc)

inVentiv Health, Inc. (Syneos Health)

Granard Pharmaceutical Sales & Marketing

Vanguard Pharma, Inc.

GTS Solution

QFR Solutions

Pharmaforce Ireland Ltd.

Sales Focus, Inc.

Amplity Health

PharmaLex GmbH

Report Scope:

In this report, the Global Pharmaceutical Contract Sales Outsourcing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Pharmaceutical Contract Sales Outsourcing Market, By Service:

Personal Promotion Non-personal Promotion

Pharmaceutical Contract Sales Outsourcing Market, By Therapeutic Area:

Cardiovascular Disorders Oncology Metabolic Disorders Neurology Orthopedic Diseases Infectious Diseases Others

Pharmaceutical Contract Sales Outsourcing Market, By Region:

North America

United States

Canada

Mexico

Europe

France

United Kingdom

Italy

Germany

Spain

Asia-Pacific

China

India

Japan

Australia

South Korea

South America

Brazil

Argentina

Colombia

Middle East & Africa

South Africa

Saudi Arabia

UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Pharmaceutical Contract Sales Outsourcing Market.

Available Customizations:

Global Pharmaceutical Contract Sales Outsourcing market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Global Pharmaceutical Contract Sales Outsourcing Market Outlook

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
• 4.2. Market Share & Forecast
  • 4.2.1. By Service (Personal Promotion (Promotional Sales Team, Key Account Management, Vacancy Management), Non-personal Promotion (Tele-detailing, Interactive E-detailing, Customer Service, Medical Science Liaisons, Patient Engagement Services, Others), Others)
  • 4.2.2. By Therapeutic Area (Cardiovascular Disorders, Oncology, Metabolic Disorders, Neurology, Orthopedic Diseases, Infectious Diseases, Others)
  • 4.2.3. By Region
  • 4.2.4. By Company (2023)
• 4.3. Market Map
  • 4.3.1. By Service
  • 4.3.2. By Therapeutic Area
  • 4.3.3. By Region

5. Asia Pacific Pharmaceutical Contract Sales Outsourcing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Service
  • 5.2.2. By Therapeutic Area
  • 5.2.3. By Country
• 5.3. Asia Pacific: Country Analysis
  • 5.3.1. China Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 5.3.1.1. Market Size & Forecast
      • 5.3.1.1.1. By Value
    • 5.3.1.2. Market Share & Forecast
      • 5.3.1.2.1. By Service
      • 5.3.1.2.2. By Therapeutic Area
  • 5.3.2. India Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 5.3.2.1. Market Size & Forecast
      • 5.3.2.1.1. By Value
    • 5.3.2.2. Market Share & Forecast
      • 5.3.2.2.1. By Service
      • 5.3.2.2.2. By Therapeutic Area
  • 5.3.3. Australia Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 5.3.3.1. Market Size & Forecast
      • 5.3.3.1.1. By Value
    • 5.3.3.2. Market Share & Forecast
      • 5.3.3.2.1. By Service
      • 5.3.3.2.2. By Therapeutic Area
  • 5.3.4. Japan Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 5.3.4.1. Market Size & Forecast
      • 5.3.4.1.1. By Value
    • 5.3.4.2. Market Share & Forecast
      • 5.3.4.2.1. By Service
      • 5.3.4.2.2. By Therapeutic Area
  • 5.3.5. South Korea Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 5.3.5.1. Market Size & Forecast
      • 5.3.5.1.1. By Value
    • 5.3.5.2. Market Share & Forecast
      • 5.3.5.2.1. By Service
      • 5.3.5.2.2. By Therapeutic Area

6. Europe Pharmaceutical Contract Sales Outsourcing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Service
  • 6.2.2. By Therapeutic Area
  • 6.2.3. By Country
• 6.3. Europe: Country Analysis
  • 6.3.1. France Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Service
      • 6.3.1.2.2. By Therapeutic Area
  • 6.3.2. Germany Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Service
      • 6.3.2.2.2. By Therapeutic Area
  • 6.3.3. Spain Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Service
      • 6.3.3.2.2. By Therapeutic Area
  • 6.3.4. Italy Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 6.3.4.1. Market Size & Forecast
      • 6.3.4.1.1. By Value
    • 6.3.4.2. Market Share & Forecast
      • 6.3.4.2.1. By Service
      • 6.3.4.2.2. By Therapeutic Area
  • 6.3.5. United Kingdom Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 6.3.5.1. Market Size & Forecast
      • 6.3.5.1.1. By Value
    • 6.3.5.2. Market Share & Forecast
      • 6.3.5.2.1. By Service
      • 6.3.5.2.2. By Therapeutic Area

7. North America Pharmaceutical Contract Sales Outsourcing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Service
  • 7.2.2. By Therapeutic Area
  • 7.2.3. By Country
• 7.3. North America: Country Analysis
  • 7.3.1. United States Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Service
      • 7.3.1.2.2. By Therapeutic Area
  • 7.3.2. Mexico Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Service
      • 7.3.2.2.2. By Therapeutic Area
  • 7.3.3. Canada Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Service
      • 7.3.3.2.2. By Therapeutic Area

8. South America Pharmaceutical Contract Sales Outsourcing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Service
  • 8.2.2. By Therapeutic Area
  • 8.2.3. By Country
• 8.3. South America: Country Analysis
  • 8.3.1. Brazil Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Service
      • 8.3.1.2.2. By Therapeutic Area
  • 8.3.2. Argentina Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Service
      • 8.3.2.2.2. By Therapeutic Area
  • 8.3.3. Colombia Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Service
      • 8.3.3.2.2. By Therapeutic Area

9. Middle East and Africa Pharmaceutical Contract Sales Outsourcing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Service
  • 9.2.2. By Therapeutic Area
  • 9.2.3. By Country
• 9.3. MEA: Country Analysis
  • 9.3.1. South Africa Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Service
      • 9.3.1.2.2. By Therapeutic Area
  • 9.3.2. Saudi Arabia Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Service
      • 9.3.2.2.2. By Therapeutic Area
  • 9.3.3. UAE Pharmaceutical Contract Sales Outsourcing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Service
      • 9.3.3.2.2. By Therapeutic Area

10. Market Dynamics

• 10.1. Drivers
• 10.2. Challenges

11. Market Trends & Developments

• 11.1. Recent Developments
• 11.2. Product Launches
• 11.3. Mergers & Acquisitions

12. Global Pharmaceutical Contract Sales Outsourcing Market: SWOT Analysis

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Product

14. Competitive Landscape

• 14.1. Ashfield (UDG Healthcare plc)
  • 14.1.1. Business Overview
  • 14.1.2. Company Snapshot
  • 14.1.3. Product & Services
  • 14.1.4. Financials (In case of listed)
  • 14.1.5. Recent Developments
  • 14.1.6. Key Personnel Details
  • 14.1.7. SWOT Analysis
• 14.2. inVentiv Health, Inc. (Syneos Health)
• 14.3. Granard Pharmaceutical Sales & Marketing
• 14.4. Vanguard Pharma, Inc.
• 14.5. GTS Solution
• 14.6. QFR Solutions
• 14.7. Pharmaforce Ireland Ltd.
• 14.8. Sales Focus, Inc.
• 14.9. Amplity Health
• 14.10.PharmaLex GmbH

15. Strategic Recommendations

16. About Us & Disclaimer